Searched for
OPHTHALMIC PRODUCTS
For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some not- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%
- Sun Pharma: How a small Kolkata trader became a global buyout artist
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 33%To get clarity on the markets, there are three questions to which you need answers. First: When will the war end? Second: How long will it ...20 Apr, 2026, 12.10 PM IST
- Glenmark launches generic ophthalmic solution in US marketGlenmark Pharmaceuticals' subsidiary has introduced Latanoprost ophthalmic solution, a generic medication for glaucoma, in the US market. T...14 Feb, 2025, 10.07 AM IST
- Glenmark launches generic glaucoma treatment ophthalmic solutionGlenmark Pharmaceuticals Inc., USA launched a generic version of Travatan Z, a glaucoma treatment, called Travoprost ophthalmic solution (0...27 Nov, 2024, 10.42 AM IST
- Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solutionAlembic Pharmaceuticals Ltd has obtained final approval from the US FDA for its generic Bromfenac ophthalmic solution, used to treat postop...10 Jul, 2024, 05.07 PM IST
- Lupin gets USFDA nod for Bromfenac Ophthalmic SolutionPharma major Lupin on Wednesday said it has received approval from the US health regulator to market its generic Bromfenac Ophthalmic Solut...16 Aug, 2023, 03.52 PM IST
- Teva launches Indoco Remedies-developed generic drug in USThe product, which is a generic version of Azopt ophthalmic suspension, is developed and manufactured by the Mumbai-based drug firm at its ...09 Mar, 2021, 03.15 PM IST
- Alembic Pharma gets USFDA nod for 2 generic productsThe product is generic version of Sanofi-Aventis US LLC's Aubagio tablets in the same strengths.22 Apr, 2019, 03.13 PM IST
- Alembic Pharmaceuticals gets USFDA nod for ophthalmic solutionThe company has received approval from the USFDA for its abbreviated new drug application (ANDA) Olopatadine Hydrochloride ophthalmic solut...10 Dec, 2018, 12.14 PM IST
- Local pharma formulators to benefit from new USFDA generic guidance: ReportThis will help domestic pharma formulators with pending ANDA approvals to reduce review cycles and expedite approvals, says a weekend repor...28 Oct, 2018, 12.27 PM IST
- Sun Pharma receives USFDA nod ophthalmic solution used to treat dry eye diseaseNew Delhi, Aug 16 () Sun Pharma has received approval from the US health regulator for CEQUA (cyclosporine ophthalmic solution), used to in...16 Aug, 2018, 11.32 AM IST
- Alembic Pharma gets tentative USFDA nod for ophthalmic solutionAlembic said it is currently in litigation with Allergan in District Court of New Jersey and the launch of this product will depend on the ...06 Aug, 2018, 12.33 PM IST
- Sun Pharma makes tender offer to acquire InSite VisionSun Pharmaceutical Industries has made a tender offer to acquire US-based eyecare firm InSite Vision for USD 0.35 per share in cash.29 Sep, 2015, 08.07 PM IST
- Sun Pharma plans to buy US-based eye care company InSite VisionSun Pharma said one of its subsidiaries plans to acquire US-based InSite Vision, a company that develops specialty ophthalmic, or eye care ...17 Sep, 2015, 04.00 AM IST
- Lupin completes acquisition of Mexico's Laboratories GrinMexico is one of the fastest growing pharmaceutical markets in the world valued at over $ 13.5 billion and growing at 9-10% annually.01 Oct, 2014, 09.08 PM IST
- Lupin buys Mexico's Laboratorios Grin; forays into LATAM mkt"The acquisition marks Lupin's foray into the high growth Mexican and the larger Latin American (LATAM) pharmaceuticals market," Lupin Ltd ...27 Mar, 2014, 02.13 PM IST
- Lupin launches generic ophthalmic solution in US marketLupin launched generic version of Allergan Inc's Zymaxid Ophthalmic Solution in US market with 180 days of marketing exclusivity.03 Oct, 2013, 11.27 AM IST
- Indoco in JV to sell ophthalmic products in USIndoco Remedies has formalised a joint venture agreement with New Jersey-based Amneal Pharmaceuticals to market 10 ophthalmic products in t...22 Oct, 2007, 12.00 AM IST
Load More
